Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Electromagnetic field radiation is a form of energy composed of oscillating electric and magnetic fields, spanning frequencies from very low (ELF) to microwave and radiofrequency ranges. It is ubiquitous due to natural and anthropogenic sources, with growing exposure from wireless technology and infrastructure. EMF radiation can penetrate biological tissues, inducing biological effects primarily through indirect mechanisms, notably by disrupting voltage-gated ion channel function in cell membranes, triggering overproduction of reactive oxygen species, oxidative stress, DNA damage, and cellular dysfunction. These effects have been linked to carcinogenic processes, reproductive disorders, neurological impairments, and electro-hypersensitivity. Despite widespread exposure, EMF radiation is classified by international agencies (IARC) as a possible carcinogen, yet it lacks the properties and specificity required to be considered a molecular therapeutic target or receptor[1][2][3].
Not applicable; EMF radiation is not targeted by drugs.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Electromagnetic field radiation (EMF radiation).